drugdeliverybusiness15h
Abbott leader, expert discuss stigma around diabetes management
Abbott (NYSE:ABT) is launching a new initiative that takes a look at some of the stigmas and stereotypes that come with ...
drugdeliverybusiness20h
Glucotrack completes first-in-human continuous blood glucose monitor implant study
Glucotrack (Nasdaq:GCTK) announced today that it completed the first-in-human clinical study of its continuous blood glucose ...
drugdeliverybusiness15h
Abbott launches initiative to combat diabetes stigma
Abbott (NYSE:ABT) today unveiled a new initiative addressing the biases and stigmas associated with diabetes management.
drugdeliverybusiness1d
Fractyl Health announces layoffs as it pivots to gene therapy
Fractyl Health is cutting nearly a fifth of its workforce as it streamlines resources and shifts focus toward certain ...
drugdeliverybusiness1d
Modular Medical takes step forward in CE mark process for insulin pump tech
Modular Medical develops patented insulin delivery technologies, aiming to improve access to glycemic control. Its founder, ...
drugdeliverybusiness2d
Beta Bionics goes public with upsized $234.6M IPO
Beta Bionics announced today that it went public after pricing a significantly upsized initial public offering (IPO).
drugdeliverybusiness3d
Trinity Biotech expects to submit ‘disruptive’ next-gen CGM to FDA in 2026
(Nasdaq:TRIB) announced new pre-pivotal clinical data supporting its next-generation continuous glucose monitor (CGM) system.
drugdeliverybusiness5d
Beta Bionics to raise $114.4M in IPO
Beta Bionics today filed a prospectus outlining its aim to bring in $114.4 million in its initial public offering (IPO).